In this blog piece from our charity partner World Cancer Research Fund, Rachel Thompson tells us about the link between alcohol consumption and breast cancer.
Find out about how the UK’s National Physical Laboratory (NPL) is enabling greater confidence in radiotherapy, leading to accelerated implementation of the most advanced techniques and helping to ensure patients receive the same standard of treatment irrespective of where they receive their treatment.
To mark our focus on social media in cancer care we recently spoke with Deanna Attai from the University of California (CA, USA) about the potential use of social media in cancer care including how oncologists can incorporate social media into their care plans as well as the opportunities and risks they should be aware of
Armed with over 10 years of positive EU experience, a significant logical and well-founded evolution is underway with biosimilar medicines offering great benefits for all involved in the healthcare system. Julie Maréchal-Jamil from Biosimilar Medicines group (a Medicines for Europe sector group) explains.
What advances have been made in immune therapy for renal cell carcinoma? Discover what the experts say in this opinion article from Future Oncology.
To mark Rare Disease Day, Oncology Central brings you an exclusive opinion piece written by two of the principal investigators of a pivotal immunotherapy clinical trial designed specifically for rare cancer patients.
Following the continuing evolution of cancer immunotherapy, this featured article discusses how image-guided, minimally invasive therapies and immuno-oncology agents may be combined – could there be resultant synergy between these two modalities?
This exclusive opinion piece debates the use of therapeutic agents already established for other conditions for the treatment of cancer.